PMID- 25631469 OWN - NLM STAT- MEDLINE DCOM- 20160629 LR - 20181202 IS - 1878-0210 (Electronic) IS - 1878-0210 (Linking) VI - 9 IP - 5 DP - 2015 Oct TI - Healthcare utilization and costs following newly diagnosed type-2 diabetes in Sweden: A follow-up of 38,956 patients in a clinical practice setting. PG - 330-7 LID - S1751-9918(15)00002-9 [pii] LID - 10.1016/j.pcd.2015.01.001 [doi] AB - AIMS: To describe healthcare resource use patterns and estimate healthcare costs of newly diagnosed Type 2 diabetes mellitus (T2DM) patients in Sweden. METHODS: Patients with a newly diagnosed T2DM between 1999 and 2009 were identified from 84 Swedish primary care centres. Healthcare resource use data, excluding pharmaceuticals, were extracted from electronic patient records and a national patient register, and reported as per patient mean number of primary care contacts, laboratory tests and hospitalizations. Per patient mean healthcare costs are reported as annual and cumulative costs. RESULTS: During a median (maximum) of 4.6 (9.0) years follow-up; 38,956 patients (183,513 patient years) on average made 81 primary care contacts, was hospitalized 2.14 times, and took 31 laboratory tests. Mean per patient annual healthcare costs were euro4128 (95% CI, 4054-4199) the first year after diagnosis, euro2708 (95% CI, 2641-2776) the second year, and euro3030 (95% CI, 2854-3204) in year 9 (2012 values). Mean per patient cumulative healthcare costs were euro26,503 (95% CI, 26,025-26,970) at 9 years of follow-up. Hospitalizations accounted for the majority of healthcare costs. CONCLUSIONS: Although newly diagnosed T2DM patients require a substantial amount of healthcare services in primary care, hospitalizations account for the majority of healthcare costs. CI - Copyright (c) 2015 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved. FAU - Sabale, Ugne AU - Sabale U AD - AstraZeneca Nordic-Baltic, Sodertalje, Sweden. Electronic address: ugne.sabale@astrazeneca.com. FAU - Bodegard, Johan AU - Bodegard J AD - AstraZeneca Nordic-Baltic, Sodertalje, Sweden. FAU - Sundstrom, Johan AU - Sundstrom J AD - Uppsala University, Uppsala, Sweden. FAU - Ostgren, Carl Johan AU - Ostgren CJ AD - Linkoping University, Linkoping, Sweden. FAU - Nilsson, Peter AU - Nilsson P AD - Lund University, Malmo, Sweden. FAU - Johansson, Gunnar AU - Johansson G AD - Uppsala University, Uppsala, Sweden. FAU - Svennblad, Bodil AU - Svennblad B AD - Uppsala University, Uppsala, Sweden. FAU - Henriksson, Martin AU - Henriksson M AD - AstraZeneca Nordic-Baltic, Sodertalje, Sweden. LA - eng PT - Journal Article PT - Observational Study PT - Research Support, Non-U.S. Gov't DEP - 20150124 PL - England TA - Prim Care Diabetes JT - Primary care diabetes JID - 101463825 SB - IM MH - Aged MH - Diabetes Mellitus, Type 2/diagnosis/*economics/*therapy MH - Diagnostic Tests, Routine/economics MH - Electronic Health Records MH - Female MH - Follow-Up Studies MH - *Health Care Costs/trends MH - Health Resources/*economics/statistics & numerical data/trends MH - Hospital Costs MH - House Calls/economics MH - Humans MH - Male MH - Middle Aged MH - Office Visits/economics MH - Primary Health Care/*economics/statistics & numerical data/trends MH - Registries MH - Retrospective Studies MH - Sweden MH - Time Factors MH - Treatment Outcome OTO - NOTNLM OT - Healthcare utilization, Healthcare costs, Retrospective observational study OT - Type 2 diabetes mellitus EDAT- 2015/01/30 06:00 MHDA- 2016/06/30 06:00 CRDT- 2015/01/30 06:00 PHST- 2014/06/04 00:00 [received] PHST- 2014/12/14 00:00 [revised] PHST- 2015/01/03 00:00 [accepted] PHST- 2015/01/30 06:00 [entrez] PHST- 2015/01/30 06:00 [pubmed] PHST- 2016/06/30 06:00 [medline] AID - S1751-9918(15)00002-9 [pii] AID - 10.1016/j.pcd.2015.01.001 [doi] PST - ppublish SO - Prim Care Diabetes. 2015 Oct;9(5):330-7. doi: 10.1016/j.pcd.2015.01.001. Epub 2015 Jan 24.